Correlation of Cognition With Disability and Physical Performance in Patients With Relapsing-Remitting MS.

IF 2.6 Q2 CLINICAL NEUROLOGY
Journal of Central Nervous System Disease Pub Date : 2025-06-17 eCollection Date: 2025-01-01 DOI:10.1177/11795735251349716
Marko Luostarinen, Anne M Portaankorva, Pirjo Urpilainen, Saara Takala, Mika Venojärvi
{"title":"Correlation of Cognition With Disability and Physical Performance in Patients With Relapsing-Remitting MS.","authors":"Marko Luostarinen, Anne M Portaankorva, Pirjo Urpilainen, Saara Takala, Mika Venojärvi","doi":"10.1177/11795735251349716","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cognitive impairment is common in patients with multiple sclerosis (MS). Physical activity is clearly linked to cognitive performance, and several studies have shown the importance of regular cognition testing, but such testing is still not routinely performed in clinical practice.</p><p><strong>Objective: </strong>This study aimed to investigate the association between cognition, disability, and physical performance in relapsing-remitting MS (RRMS) patients.</p><p><strong>Methods: </strong>A total of 41 patients with RRMS with an Expanded Disability Status Scale (EDSS) level of 0-5.5 and 20 healthy controls completed the MS Functional Composite (MSFC) test and the Symbol Digit Modality Test (SDMT). Six-Minute Walk (6MW) was evaluated for all participants, and they used an accelerometer for seven days.</p><p><strong>Results: </strong>A significant correlation was found between cognition and disability level measured by the MSFC (MSFC/SDMT, r = 0.668, <i>P</i> = .001) and between disability and 6MW (EDSS/6MW, r = -0.516, <i>P</i> = .001; MSFC/6MW, r = 0.348, <i>P</i> = .028) in the patients' group. Cognition results (SDMT) were statistically significantly weaker in patients with EDSS >2.5 vs EDSS ≤2.5 or control group. Total daily activity (MVPS) correlated with cognition as measured by the SDMT in the control group but not in the patients' group. In the EDSShigh group, better results on the 6MW test were associated with better cognition results as measured by the SDMT (r = 0.505, <i>P</i> = .039).</p><p><strong>Conclusion: </strong>There was a clear association between disability, 6MW and cognition. Better results on the 6MW predicted better cognition and disability.Clinical trial registration number: NCT04115930.</p>","PeriodicalId":15218,"journal":{"name":"Journal of Central Nervous System Disease","volume":"17 ","pages":"11795735251349716"},"PeriodicalIF":2.6000,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12174663/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Central Nervous System Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/11795735251349716","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cognitive impairment is common in patients with multiple sclerosis (MS). Physical activity is clearly linked to cognitive performance, and several studies have shown the importance of regular cognition testing, but such testing is still not routinely performed in clinical practice.

Objective: This study aimed to investigate the association between cognition, disability, and physical performance in relapsing-remitting MS (RRMS) patients.

Methods: A total of 41 patients with RRMS with an Expanded Disability Status Scale (EDSS) level of 0-5.5 and 20 healthy controls completed the MS Functional Composite (MSFC) test and the Symbol Digit Modality Test (SDMT). Six-Minute Walk (6MW) was evaluated for all participants, and they used an accelerometer for seven days.

Results: A significant correlation was found between cognition and disability level measured by the MSFC (MSFC/SDMT, r = 0.668, P = .001) and between disability and 6MW (EDSS/6MW, r = -0.516, P = .001; MSFC/6MW, r = 0.348, P = .028) in the patients' group. Cognition results (SDMT) were statistically significantly weaker in patients with EDSS >2.5 vs EDSS ≤2.5 or control group. Total daily activity (MVPS) correlated with cognition as measured by the SDMT in the control group but not in the patients' group. In the EDSShigh group, better results on the 6MW test were associated with better cognition results as measured by the SDMT (r = 0.505, P = .039).

Conclusion: There was a clear association between disability, 6MW and cognition. Better results on the 6MW predicted better cognition and disability.Clinical trial registration number: NCT04115930.

复发-缓解型多发性硬化症患者的认知与残疾和身体表现的相关性。
背景:认知障碍在多发性硬化症(MS)患者中很常见。体育活动显然与认知表现有关,一些研究已经表明了定期认知测试的重要性,但这种测试在临床实践中仍然没有常规进行。目的:本研究旨在探讨复发-缓解型多发性硬化症(RRMS)患者的认知、残疾和身体表现之间的关系。方法:41例扩展残疾状态量表(EDSS)水平为0 ~ 5.5的RRMS患者和20例健康对照者分别完成MS功能复合测试(MSFC)和符号数字模态测试(SDMT)。对所有参与者进行6分钟步行(6MW)评估,他们使用加速度计7天。结果:认知与MSFC测量的残疾水平(MSFC/SDMT, r = 0.668, P = .001)、残疾与6MW (EDSS/6MW, r = -0.516, P = .001)存在显著相关;MSFC/6MW, r = 0.348, P = 0.028)。与EDSS≤2.5或对照组相比,EDSS≤2.5的患者认知结果(SDMT)明显较弱。总每日活动(MVPS)与认知相关的SDMT测量在对照组,而不是在患者组。在eds高组中,6MW测试的较好结果与SDMT测量的较好的认知结果相关(r = 0.505, P = 0.039)。结论:残疾、6MW与认知有明显的相关性。6MW测试结果越好,预示着认知能力和残疾程度越好。临床试验注册号:NCT04115930。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.90
自引率
0.00%
发文量
39
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信